Dihydroartemisinin–piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study

BACKGROUND: Artemisinin resistance in Plasmodium falciparum threatens to reduce the efficacy of artemisinin combination therapies (ACTs), thus compromising global efforts to eliminate malaria. Recent treatment failures with dihydroartemisinin-piperaquine, the current first-line ACT in Cambodia, sugg...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Lancet Infect Dis
Autors principals: Amaratunga, Chanaki, Lim, Pharath, Suon, Seila, Sreng, Sokunthea, Mao, Sivanna, Sopha, Chantha, Sam, Baramey, Dek, Dalin, Try, Vorleak, Amato, Roberto, Blessborn, Daniel, Song, Lijiang, Tullo, Gregory S, Fay, Michael P, Anderson, Jennifer M, Tarning, Joel, Fairhurst, Rick M
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4792715/
https://ncbi.nlm.nih.gov/pubmed/26774243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(15)00487-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars